CSR Fluid Management and Edema Control 2 — Questions and Answers
Question 1: In peritoneal dialysis, osmotic fluid removal is driven by which agent in the dialysate, and what is the primary nutritional complication of its use?
- Sodium chloride — no nutritional complication
- Glucose (dextrose) — absorbed from the peritoneal cavity causing increased caloric intake, hyperglycemia (especially in diabetics), hyperlipidemia, and obesity (Correct answer)
- Phosphate buffer — hyperphosphatemia from dialysate absorption
- Urea — nitrogen absorption worsening uremia
Correct answer: Glucose (dextrose) — absorbed from the peritoneal cavity causing increased caloric intake, hyperglycemia (especially in diabetics), hyperlipidemia, and obesity
PD dialysate uses glucose as the osmotic agent. Between 200–800 kcal/day is absorbed from dialysate glucose, contributing to hyperglycemia (in diabetic and non-diabetic patients), hypertriglyceridemia, and obesity — significant nutritional complications unique to PD.
PD osmotic agents: Conventional: glucose/dextrose (1.5%, 2.5%, 4.25% concentrations). Higher glucose concentration = more osmotic pressure = more ultrafiltration. Glucose absorption: ~60–80% of instilled glucose absorbed per exchange. Total absorption: 200–800 kcal/day depending on concentration used and number of exchanges. Metabolic consequences: (1) Hyperglycemia: insulin resistance + glucose absorption → poor glycemic control in diabetics; non-diabetic patients may develop glucose intolerance; (2) Hypertriglyceridemia: absorbed glucose → hepatic TG synthesis; PD patients have higher TG levels than HD; (3) Obesity: 5–10 kg weight gain over 2–3 years on CAPD is common; (4) Malnutrition underdiagnosis: weight gain masks PEW. Dietary implications: subtract dialysate glucose calories from total energy prescription; target reduced dietary fat for dyslipidemia management; reduce simple carbohydrates. Alternatives: icodextrin (polysaccharide, not significantly absorbed, used once daily for long dwells) — no significant glucose absorption, suitable for diabetics and patients with ultrafiltration failure.
Question 2: A peritoneal dialysis patient switches from CAPD to automated peritoneal dialysis (APD) with one long 'wet' daytime dwell. How does this change fluid management and nutritional considerations?
- APD eliminates all fluid management concerns as the machine removes all fluid overnight
- APD with icodextrin for the daytime dwell allows more consistent ultrafiltration; icodextrin (large polysaccharide) is metabolized to maltose and may affect glucose monitoring using certain glucometers — clinical dietitian must counsel on this interaction (Correct answer)
- APD requires higher protein intake than CAPD due to machine-related protein losses
- Fluid management is identical between CAPD and APD; no dietary adjustments needed
Correct answer: APD with icodextrin for the daytime dwell allows more consistent ultrafiltration; icodextrin (large polysaccharide) is metabolized to maltose and may affect glucose monitoring using certain glucometers — clinical dietitian must counsel on this interaction
APD patients often use icodextrin for the long daytime dwell. Icodextrin metabolites (maltose, maltotriose) interfere with glucose oxidase-based glucometers, causing falsely elevated glucose readings. This affects diabetes management decisions and is a critical safety counseling point for the dietitian.
Icodextrin (Extraneal) — 7.5% polyglucose osmotic agent: absorbed minimally (~20 g/day of oligosaccharides absorbed), metabolized to maltose, maltotriose, polysaccharide chains. Provides sustained ultrafiltration for 8–12-hour long dwells (better than glucose which is absorbed and loses osmotic effect rapidly). Glucose monitoring interaction: Glucose oxidase (GO) method glucometers — NOT affected by maltose (safe: Accu-Chek). Glucose dehydrogenase pyrroloquinoline quinone (GDH-PQQ) method glucometers — maltose FALSELY READS as glucose, causing glucose dehydrogenase meters to report dangerously elevated 'glucose' values (e.g., 500–600 mg/dL when actual glucose is 100 mg/dL). Clinical risk: insulin overdosing based on false high reading → hypoglycemia → death. Warning: FDA safety alert for GDH-PQQ meters with icodextrin. All PD patients on icodextrin must use ONLY GO-based glucometers (Accu-Chek). Dietitian educates: read glucometer manual, carry medical alert about icodextrin use.
Question 3: For a CKD patient with resistant edema being treated with IV furosemide, the dietitian notes the patient is consuming 5 g/day of sodium. How much sodium reduction is needed to achieve < 2.3 g/day, and what is the most practical first step?
- A reduction of 2.7 g/day is needed; start by eliminating added salt at the table and during cooking (typically ~1.5–2 g/day reduction) (Correct answer)
- A reduction of 0.7 g/day is needed; just slightly reduce salt
- No reduction is needed as the patient is already close to the target
- Immediately eliminate all sodium from the diet
Correct answer: A reduction of 2.7 g/day is needed; start by eliminating added salt at the table and during cooking (typically ~1.5–2 g/day reduction)
5 g/day - 2.3 g/day target = 2.7 g/day reduction needed. Eliminating discretionary salt (table salt and cooking salt) typically removes 1.5–2 g/day. The remaining ~0.7–1.2 g reduction requires targeting processed/packaged foods, which contain ~80% of dietary sodium.
Sources of sodium in the typical Western diet: Processed/packaged foods: ~80% of total sodium intake (canned soups, frozen meals, condiments, cheese, deli meats, fast food); Naturally occurring: ~10% (in meats, dairy, vegetables); Discretionary (added salt): ~10%. Practical reduction strategy for 2.7 g/day reduction: (1) Table and cooking salt elimination: ~1.5–2 g/day reduction (most visible, patient-controlled); (2) Target highest-sodium processed foods: switch canned soups from 800–1000 mg/cup to low-sodium (<140 mg/cup) versions; eliminate processed deli meats (1000–1500 mg/3 oz); reduce soy sauce/condiment use; avoid pickled foods; (3) Label reading: identify foods > 600 mg sodium per serving as 'high sodium'; aim for < 300 mg/serving when possible; (4) DASH-like substitutions: fresh vs. canned vegetables, fresh meats vs. processed; herb seasoning vs. sodium-containing seasonings (garlic salt vs. garlic powder). Goal: 90-day follow-up to reassess dietary sodium and edema response.
Question 4: A hemodialysis patient reports drinking 2.5 L of fluid daily despite a 1.5 L/day restriction. On dietary assessment, the dietitian finds that the patient is not counting soup, yogurt, ice cream, and frozen fruit as 'fluids.' What is the appropriate educational intervention?
- Inform the patient that only liquids from a cup or glass count as 'fluid'
- Educate the patient that ALL foods that are liquid at room temperature (soups, gelatin, ice cream, pudding, yogurt) AND high-water-content foods (watermelon, frozen fruit) must be counted as part of the fluid allowance (Correct answer)
- Revise the fluid restriction upward to accommodate the patient's actual intake
- No intervention needed as non-beverage fluids are not clinically significant
Correct answer: Educate the patient that ALL foods that are liquid at room temperature (soups, gelatin, ice cream, pudding, yogurt) AND high-water-content foods (watermelon, frozen fruit) must be counted as part of the fluid allowance
Any food that is liquid at room temperature (ice melts, gelatin melts, soups, ice cream) counts as fluid intake. Many patients incorrectly believe only beverages count. Hidden fluid sources routinely cause patients to significantly exceed prescribed limits.
Hidden fluid sources in renal patient diets: Obvious: water, milk, juice, coffee, tea, soda (8 oz = 240 mL each). Hidden sources commonly missed by patients: Soups/broth: 1 cup = 240 mL; Gelatin (Jell-O): 1/2 cup = 120 mL; Ice cream/sherbet: 1/2 cup = ~100 mL (50% fluid); Frozen yogurt: 1/2 cup = ~100 mL; Pudding/custard: 1/2 cup = ~120 mL; Yogurt: 6 oz = ~120 mL; Popsicles/ice pops: 1 = 80 mL; Ice chips: volume of ice = 2× the water content (1 cup ice = ~120 mL fluid); High-water fruits/vegetables: watermelon 92% water (1 cup = ~220 mL fluid content); grapes, cucumbers, tomatoes (~90% water). Practical tool: fluid tracking log or smartphone app; teach patient to count everything in a measuring cup. Dietitian creates personalized list of patient's common 'hidden fluid' foods. Target: daily fluid log reviewed at each clinical visit.
Question 5: Bioelectrical impedance analysis (BIA) or bioimpedance spectroscopy (BIS) is used to assess fluid status in dialysis patients. When should BIA/BIS be performed for the MOST accurate measurement of dry weight?
- Before the dialysis session while the patient is in their fluid-overloaded state
- Immediately after dialysis (post-HD), when the patient is at or near their dry weight/target weight — minimizing the fluid excess that confounds measurement (Correct answer)
- 24 hours after dialysis when fluid has redistributed
- During dialysis to track real-time fluid removal
Correct answer: Immediately after dialysis (post-HD), when the patient is at or near their dry weight/target weight — minimizing the fluid excess that confounds measurement
BIA/BIS measures body fluid compartments based on electrical impedance. Post-dialysis measurement (after achieving target/dry weight) provides the most accurate baseline body composition assessment, as the pre-dialysis fluid excess would overestimate extracellular fluid and underestimate dry body mass.
Bioelectrical impedance spectroscopy (BIS, e.g., BCM — Body Composition Monitor, Fresenius) uses multiple frequencies (5 kHz to 1 MHz) to separate total body water into extracellular water (ECW) and intracellular water (ICW). Fluid overload index (FO) = measured ECW minus normal ECW for lean tissue. Assessment timing for dialysis patients: (1) Post-HD BIS: most accurate — patient near euvolemia; provides FO, lean tissue mass, fat tissue mass; informs whether target weight needs adjustment; (2) Pre-HD BIS: overestimates ECW and FO due to fluid accumulation; used clinically to guide UF goal for the upcoming session. Positioning: supine, standardized electrode placement (hand/foot or hand/upper arm methods). Contraindications: cardiac pacemakers/defibrillators, metallic implants, pregnancy. BIS clinical application: detect chronic fluid overload (FO > +2.5 L predicts increased mortality); detect underhydration (dry weight set too low, FO < -1.1 L); guide dry weight reassessment during acute illness (malnutrition → reduced lean mass → lower true dry weight).
Question 6: A CKD Stage 5 (non-dialysis) patient has developed hyponatremia (Na 128 mEq/L) and gross edema. Lab confirms low urine sodium (<20 mEq/L). What does low urine sodium indicate in this context, and what dietary intervention is appropriate?
- Low urine sodium means the patient has been excreting too much sodium and needs sodium supplementation
- Low urine sodium indicates avid renal sodium retention (RAAS/aldosterone activation, reduced GFR); the appropriate intervention is NOT sodium supplementation but sodium restriction combined with fluid restriction, as more sodium would worsen edema further (Correct answer)
- Low urine sodium is a normal finding in CKD Stage 5 and requires no intervention
- Immediately administer normal saline IV to replete sodium deficit
Correct answer: Low urine sodium indicates avid renal sodium retention (RAAS/aldosterone activation, reduced GFR); the appropriate intervention is NOT sodium supplementation but sodium restriction combined with fluid restriction, as more sodium would worsen edema further
In edematous hyponatremia, low urine sodium reflects avid renal sodium reabsorption (kidneys holding onto sodium to maintain perceived volume). This is dilutional hyponatremia — total body sodium is ELEVATED (causing edema), but serum sodium is low because water retention exceeds sodium retention. Treatment: sodium + fluid restriction, not sodium supplementation.
Interpretation of urine sodium in edema: Urine Na < 20 mEq/L in edematous states = 'avid sodium retention' = RAAS/aldosterone-mediated tubular sodium reabsorption. This pattern is seen in: heart failure, cirrhosis, nephrotic syndrome, advanced CKD with reduced GFR. Total body sodium is ELEVATED (reflected by edema = sodium + water in interstitium/pleural/peritoneal spaces), but serum sodium is 'diluted' by proportionally greater water retention (ADH activation from perceived effective arterial underfilling). Mistake: treating serum sodium of 128 mEq/L with sodium supplementation → worsens edema, may precipitate pulmonary edema. Correct approach: sodium restriction (< 2 g/day) removes the stimulus for RAAS activation; fluid restriction (~ 1 L/day in severe cases); loop diuretics to enhance sodium/water excretion (if residual renal function); dialysis initiation if no response and GFR < 10 mL/min. Serum sodium normalizes as volume overload is corrected.
CSR Fluid Management and Edema Control 2
In peritoneal dialysis, osmotic fluid removal is driven by which agent in the dialysate, and what is the primary nutritional complication of its use?